Skip to content

Mirion Technologies MIR Medical Segment — Translation adjustment

Other segment segments

Nuclear & Safety
-$9.6M-172%

Similar metrics at other companies

Medtronic logo
MDTMedical Surgical — Currency translation and other
$110M-84.8%
McKesson logo
MCKMedical-Surgical Solutions — Foreign currency translation adjustments, net
$0
Cognizant logo
CTSHHealth Sciences — Foreign currency translation adjustments
$5M+254%
Medline, Inc.
 logo
MDLNMedline Brand — Currency translation adjustments
-$2M-200%
Procter & Gamble logo
PGHealth Care — Translation and other
-$76M-155%
Nasdaq, Inc. logo
NDAQMarket Services — Foreign currency translation adjustments
-$31M-126%

Other financials

Income statement

See full
Revenue$257.6M+27.5%
Gross profit$119.1M+23.9%
Operating income$3.7M-57.5%
Net income-$3.4M-1,233%
EPS (diluted)-$0.01

Balance sheet

See full
Cash & equivalents$400.8M+115%
Total debt$478.3M-33.5%
Total equity$1.8B+22.2%
Total assets$3.5B+34.7%

Cash flow

See full
Operating cash flow$18.9M-46.9%
CapEx$9.5M+11.8%
Free cash flow$9.4M-65.3%

Valuation

See full
Market cap$4.55B+35.0%

Profitability

See full
Gross margin47.1%+0.1pp
Operating margin4.7%+0.3pp
Net margin2.6%
FCF margin9.1%-0.6pp

Returns & leverage

See full
Return on equity1.5%
Debt / equity0.3×-0.2×
Current ratio3.2×+1.0×

Where this comes from

Reported directly by Mirion Technologies in its filing.

Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.

The official record: Mirion Technologies’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mirion Technologies's medical segment — translation adjustment.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mirion Technologies's medical segment — translation adjustment?
Mirion Technologies (MIR) reported medical segment — translation adjustment of $0 in Q1 2026.
What does medical segment — translation adjustment mean?
Captures the impact of foreign currency exchange rate fluctuations on the financial position of the Medical segment's international operations. This adjustment is necessary when consolidating foreign subsidiary balance sheets into the reporting currency. It provides insight into the segment's exposure to global currency volatility and the geographic diversity of its medical product footprint.